id	sid	tid	token	lemma	pos
cord-344375-pr6jlc5c	1	1	key	key	NNP
cord-344375-pr6jlc5c	1	2	:	:	:
cord-344375-pr6jlc5c	1	3	cord-344375-pr6jlc5c	cord-344375-pr6jlc5c	JJS
cord-344375-pr6jlc5c	1	4	authors	author	NNS
cord-344375-pr6jlc5c	1	5	:	:	:
cord-344375-pr6jlc5c	1	6	Emert	Emert	NNP
cord-344375-pr6jlc5c	1	7	,	,	,
cord-344375-pr6jlc5c	1	8	Roger	Roger	NNP
cord-344375-pr6jlc5c	1	9	;	;	:
cord-344375-pr6jlc5c	1	10	Shah	Shah	NNP
cord-344375-pr6jlc5c	1	11	,	,	,
cord-344375-pr6jlc5c	1	12	Payal	Payal	NNP
cord-344375-pr6jlc5c	1	13	;	;	:
cord-344375-pr6jlc5c	1	14	Zampella	Zampella	NNP
cord-344375-pr6jlc5c	1	15	,	,	,
cord-344375-pr6jlc5c	1	16	John	John	NNP
cord-344375-pr6jlc5c	1	17	G.	G.	NNP
cord-344375-pr6jlc5c	1	18	title	title	NN
cord-344375-pr6jlc5c	1	19	:	:	:
cord-344375-pr6jlc5c	2	1	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	2	2	and	and	CC
cord-344375-pr6jlc5c	2	3	hypercoagulability	hypercoagulability	NN
cord-344375-pr6jlc5c	2	4	in	in	IN
cord-344375-pr6jlc5c	2	5	the	the	DT
cord-344375-pr6jlc5c	2	6	outpatient	outpatient	NN
cord-344375-pr6jlc5c	2	7	setting	set	VBG
cord-344375-pr6jlc5c	2	8	date	date	NN
cord-344375-pr6jlc5c	2	9	:	:	:
cord-344375-pr6jlc5c	2	10	2020	2020	CD
cord-344375-pr6jlc5c	2	11	-	-	HYPH
cord-344375-pr6jlc5c	2	12	05	05	CD
cord-344375-pr6jlc5c	2	13	-	-	HYPH
cord-344375-pr6jlc5c	2	14	23	23	CD
cord-344375-pr6jlc5c	2	15	journal	journal	NN
cord-344375-pr6jlc5c	2	16	:	:	:
cord-344375-pr6jlc5c	3	1	Thromb	Thromb	NNP
cord-344375-pr6jlc5c	3	2	Res	Res	NNP
cord-344375-pr6jlc5c	3	3	DOI	DOI	NNP
cord-344375-pr6jlc5c	3	4	:	:	:
cord-344375-pr6jlc5c	3	5	10.1016	10.1016	CD
cord-344375-pr6jlc5c	3	6	/	/	SYM
cord-344375-pr6jlc5c	3	7	j.thromres.2020.05.031	j.thromres.2020.05.031	NNP
cord-344375-pr6jlc5c	3	8	sha	sha	NN
cord-344375-pr6jlc5c	3	9	:	:	:
cord-344375-pr6jlc5c	3	10	887804f6ea215518a8e7a95b55795ad049dc56c2	887804f6ea215518a8e7a95b55795ad049dc56c2	CD
cord-344375-pr6jlc5c	3	11	doc_id	doc_id	CD
cord-344375-pr6jlc5c	3	12	:	:	:
cord-344375-pr6jlc5c	3	13	344375	344375	CD
cord-344375-pr6jlc5c	3	14	cord_uid	cord_uid	NNS
cord-344375-pr6jlc5c	3	15	:	:	:
cord-344375-pr6jlc5c	3	16	pr6jlc5c	pr6jlc5c	NNP
cord-344375-pr6jlc5c	3	17	nan	nan	NNP
cord-344375-pr6jlc5c	4	1	The	the	DT
cord-344375-pr6jlc5c	4	2	COVID-19	covid-19	CD
cord-344375-pr6jlc5c	4	3	pandemic	pandemic	NN
cord-344375-pr6jlc5c	4	4	caused	cause	VBN
cord-344375-pr6jlc5c	4	5	by	by	IN
cord-344375-pr6jlc5c	4	6	the	the	DT
cord-344375-pr6jlc5c	4	7	SARS	SARS	NNP
cord-344375-pr6jlc5c	4	8	-	-	HYPH
cord-344375-pr6jlc5c	4	9	CoV-2	CoV-2	NNP
cord-344375-pr6jlc5c	4	10	virus	virus	NN
cord-344375-pr6jlc5c	4	11	has	have	VBZ
cord-344375-pr6jlc5c	4	12	resulted	result	VBN
cord-344375-pr6jlc5c	4	13	in	in	IN
cord-344375-pr6jlc5c	4	14	an	an	DT
cord-344375-pr6jlc5c	4	15	overwhelming	overwhelming	JJ
cord-344375-pr6jlc5c	4	16	surge	surge	NN
cord-344375-pr6jlc5c	4	17	in	in	IN
cord-344375-pr6jlc5c	4	18	utilization	utilization	NN
cord-344375-pr6jlc5c	4	19	of	of	IN
cord-344375-pr6jlc5c	4	20	healthcare	healthcare	NN
cord-344375-pr6jlc5c	4	21	resources	resource	NNS
cord-344375-pr6jlc5c	4	22	.	.	.
cord-344375-pr6jlc5c	5	1	The	the	DT
cord-344375-pr6jlc5c	5	2	effect	effect	NN
cord-344375-pr6jlc5c	5	3	on	on	IN
cord-344375-pr6jlc5c	5	4	hospitals	hospital	NNS
cord-344375-pr6jlc5c	5	5	is	be	VBZ
cord-344375-pr6jlc5c	5	6	incontrovertible	incontrovertible	JJ
cord-344375-pr6jlc5c	5	7	but	but	CC
cord-344375-pr6jlc5c	5	8	the	the	DT
cord-344375-pr6jlc5c	5	9	effect	effect	NN
cord-344375-pr6jlc5c	5	10	on	on	IN
cord-344375-pr6jlc5c	5	11	outpatient	outpatient	NN
cord-344375-pr6jlc5c	5	12	services	service	NNS
cord-344375-pr6jlc5c	5	13	is	be	VBZ
cord-344375-pr6jlc5c	5	14	less	less	RBR
cord-344375-pr6jlc5c	5	15	well	well	RB
cord-344375-pr6jlc5c	5	16	-	-	HYPH
cord-344375-pr6jlc5c	5	17	studied	study	VBN
cord-344375-pr6jlc5c	5	18	.	.	.
cord-344375-pr6jlc5c	6	1	The	the	DT
cord-344375-pr6jlc5c	6	2	most	most	RBS
cord-344375-pr6jlc5c	6	3	common	common	JJ
cord-344375-pr6jlc5c	6	4	symptoms	symptom	NNS
cord-344375-pr6jlc5c	6	5	at	at	IN
cord-344375-pr6jlc5c	6	6	onset	onset	NN
cord-344375-pr6jlc5c	6	7	of	of	IN
cord-344375-pr6jlc5c	6	8	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	6	9	are	be	VBP
cord-344375-pr6jlc5c	6	10	fever	fever	NN
cord-344375-pr6jlc5c	6	11	,	,	,
cord-344375-pr6jlc5c	6	12	cough	cough	NN
cord-344375-pr6jlc5c	6	13	,	,	,
cord-344375-pr6jlc5c	6	14	fatigue	fatigue	NN
cord-344375-pr6jlc5c	6	15	,	,	,
cord-344375-pr6jlc5c	6	16	and	and	CC
cord-344375-pr6jlc5c	6	17	headache	headache	NN
cord-344375-pr6jlc5c	6	18	and	and	CC
cord-344375-pr6jlc5c	6	19	may	may	MD
cord-344375-pr6jlc5c	6	20	mimic	mimic	VB
cord-344375-pr6jlc5c	6	21	other	other	JJ
cord-344375-pr6jlc5c	6	22	common	common	JJ
cord-344375-pr6jlc5c	6	23	upper	upper	JJ
cord-344375-pr6jlc5c	6	24	respiratory	respiratory	JJ
cord-344375-pr6jlc5c	6	25	infections	infection	NNS
cord-344375-pr6jlc5c	6	26	.	.	.
cord-344375-pr6jlc5c	7	1	[	[	-LRB-
cord-344375-pr6jlc5c	7	2	1	1	CD
cord-344375-pr6jlc5c	7	3	]	]	-RRB-
cord-344375-pr6jlc5c	7	4	Patients	patient	NNS
cord-344375-pr6jlc5c	7	5	with	with	IN
cord-344375-pr6jlc5c	7	6	these	these	DT
cord-344375-pr6jlc5c	7	7	symptoms	symptom	NNS
cord-344375-pr6jlc5c	7	8	are	be	VBP
cord-344375-pr6jlc5c	7	9	likely	likely	JJ
cord-344375-pr6jlc5c	7	10	to	to	TO
cord-344375-pr6jlc5c	7	11	present	present	VB
cord-344375-pr6jlc5c	7	12	to	to	IN
cord-344375-pr6jlc5c	7	13	outpatient	outpatient	NN
cord-344375-pr6jlc5c	7	14	providers	provider	NNS
cord-344375-pr6jlc5c	7	15	.	.	.
cord-344375-pr6jlc5c	8	1	In	in	IN
cord-344375-pr6jlc5c	8	2	most	most	JJS
cord-344375-pr6jlc5c	8	3	patients	patient	NNS
cord-344375-pr6jlc5c	8	4	,	,	,
cord-344375-pr6jlc5c	8	5	symptoms	symptom	NNS
cord-344375-pr6jlc5c	8	6	will	will	MD
cord-344375-pr6jlc5c	8	7	be	be	VB
cord-344375-pr6jlc5c	8	8	mild	mild	JJ
cord-344375-pr6jlc5c	8	9	to	to	TO
cord-344375-pr6jlc5c	8	10	moderate	moderate	JJ
cord-344375-pr6jlc5c	8	11	,	,	,
cord-344375-pr6jlc5c	8	12	where	where	WRB
cord-344375-pr6jlc5c	8	13	management	management	NN
cord-344375-pr6jlc5c	8	14	for	for	IN
cord-344375-pr6jlc5c	8	15	mild	mild	JJ
cord-344375-pr6jlc5c	8	16	symptoms	symptom	NNS
cord-344375-pr6jlc5c	8	17	does	do	VBZ
cord-344375-pr6jlc5c	8	18	not	not	RB
cord-344375-pr6jlc5c	8	19	require	require	VB
cord-344375-pr6jlc5c	8	20	hospitalization	hospitalization	NN
cord-344375-pr6jlc5c	8	21	[	[	-LRB-
cord-344375-pr6jlc5c	8	22	2	2	CD
cord-344375-pr6jlc5c	8	23	]	]	-RRB-
cord-344375-pr6jlc5c	8	24	.	.	.
cord-344375-pr6jlc5c	9	1	These	these	DT
cord-344375-pr6jlc5c	9	2	patients	patient	NNS
cord-344375-pr6jlc5c	9	3	are	be	VBP
cord-344375-pr6jlc5c	9	4	encouraged	encourage	VBN
cord-344375-pr6jlc5c	9	5	to	to	TO
cord-344375-pr6jlc5c	9	6	remain	remain	VB
cord-344375-pr6jlc5c	9	7	isolated	isolated	JJ
cord-344375-pr6jlc5c	9	8	with	with	IN
cord-344375-pr6jlc5c	9	9	frequent	frequent	JJ
cord-344375-pr6jlc5c	9	10	follow	follow	NN
cord-344375-pr6jlc5c	9	11	-	-	HYPH
cord-344375-pr6jlc5c	9	12	up	up	NN
cord-344375-pr6jlc5c	9	13	with	with	IN
cord-344375-pr6jlc5c	9	14	their	-PRON-	PRP$
cord-344375-pr6jlc5c	9	15	healthcare	healthcare	NN
cord-344375-pr6jlc5c	9	16	provider	provider	NN
cord-344375-pr6jlc5c	9	17	to	to	TO
cord-344375-pr6jlc5c	9	18	assess	assess	VB
cord-344375-pr6jlc5c	9	19	their	-PRON-	PRP$
cord-344375-pr6jlc5c	9	20	respiratory	respiratory	JJ
cord-344375-pr6jlc5c	9	21	status	status	NN
cord-344375-pr6jlc5c	9	22	,	,	,
cord-344375-pr6jlc5c	9	23	with	with	IN
cord-344375-pr6jlc5c	9	24	urgent	urgent	JJ
cord-344375-pr6jlc5c	9	25	hospitalization	hospitalization	NN
cord-344375-pr6jlc5c	9	26	for	for	IN
cord-344375-pr6jlc5c	9	27	respiratory	respiratory	JJ
cord-344375-pr6jlc5c	9	28	distress	distress	NN
cord-344375-pr6jlc5c	9	29	.	.	.
cord-344375-pr6jlc5c	10	1	Factors	factor	NNS
cord-344375-pr6jlc5c	10	2	predicting	predict	VBG
cord-344375-pr6jlc5c	10	3	poor	poor	JJ
cord-344375-pr6jlc5c	10	4	outcomes	outcome	NNS
cord-344375-pr6jlc5c	10	5	include	include	VBP
cord-344375-pr6jlc5c	10	6	older	old	JJR
cord-344375-pr6jlc5c	10	7	age	age	NN
cord-344375-pr6jlc5c	10	8	,	,	,
cord-344375-pr6jlc5c	10	9	obesity	obesity	NN
cord-344375-pr6jlc5c	10	10	,	,	,
cord-344375-pr6jlc5c	10	11	diabetes	diabete	VBZ
cord-344375-pr6jlc5c	10	12	mellitus	mellitus	NN
cord-344375-pr6jlc5c	10	13	,	,	,
cord-344375-pr6jlc5c	10	14	and	and	CC
cord-344375-pr6jlc5c	10	15	hypertension	hypertension	NN
cord-344375-pr6jlc5c	10	16	[	[	-LRB-
cord-344375-pr6jlc5c	10	17	1	1	CD
cord-344375-pr6jlc5c	10	18	]	]	-RRB-
cord-344375-pr6jlc5c	10	19	.	.	.
cord-344375-pr6jlc5c	11	1	Among	among	IN
cord-344375-pr6jlc5c	11	2	hospitalized	hospitalize	VBN
cord-344375-pr6jlc5c	11	3	patients	patient	NNS
cord-344375-pr6jlc5c	11	4	with	with	IN
cord-344375-pr6jlc5c	11	5	COVID-19	covid-19	JJ
cord-344375-pr6jlc5c	11	6	,	,	,
cord-344375-pr6jlc5c	11	7	venous	venous	JJ
cord-344375-pr6jlc5c	11	8	thromboembolism	thromboembolism	NN
cord-344375-pr6jlc5c	11	9	(	(	-LRB-
cord-344375-pr6jlc5c	11	10	VTE	VTE	NNP
cord-344375-pr6jlc5c	11	11	)	)	-RRB-
cord-344375-pr6jlc5c	11	12	,	,	,
cord-344375-pr6jlc5c	11	13	and	and	CC
cord-344375-pr6jlc5c	11	14	in	in	IN
cord-344375-pr6jlc5c	11	15	particular	particular	JJ
cord-344375-pr6jlc5c	11	16	pulmonary	pulmonary	JJ
cord-344375-pr6jlc5c	11	17	emboli	emboli	NN
cord-344375-pr6jlc5c	11	18	,	,	,
cord-344375-pr6jlc5c	11	19	are	be	VBP
cord-344375-pr6jlc5c	11	20	commonly	commonly	RB
cord-344375-pr6jlc5c	11	21	diagnosed	diagnose	VBN
cord-344375-pr6jlc5c	11	22	[	[	-LRB-
cord-344375-pr6jlc5c	11	23	3	3	CD
cord-344375-pr6jlc5c	11	24	]	]	-RRB-
cord-344375-pr6jlc5c	11	25	.	.	.
cord-344375-pr6jlc5c	12	1	Recently	recently	RB
cord-344375-pr6jlc5c	12	2	,	,	,
cord-344375-pr6jlc5c	12	3	evidence	evidence	NN
cord-344375-pr6jlc5c	12	4	for	for	IN
cord-344375-pr6jlc5c	12	5	D	d	NN
cord-344375-pr6jlc5c	12	6	-	-	HYPH
cord-344375-pr6jlc5c	12	7	dimer	dimer	NN
cord-344375-pr6jlc5c	12	8	cutoff	cutoff	NN
cord-344375-pr6jlc5c	12	9	values	value	NNS
cord-344375-pr6jlc5c	12	10	that	that	WDT
cord-344375-pr6jlc5c	12	11	predict	predict	VBP
cord-344375-pr6jlc5c	12	12	high	high	JJ
cord-344375-pr6jlc5c	12	13	-	-	HYPH
cord-344375-pr6jlc5c	12	14	risk	risk	NN
cord-344375-pr6jlc5c	12	15	for	for	IN
cord-344375-pr6jlc5c	12	16	VTE	VTE	NNP
cord-344375-pr6jlc5c	12	17	has	have	VBZ
cord-344375-pr6jlc5c	12	18	been	be	VBN
cord-344375-pr6jlc5c	12	19	demonstrated	demonstrate	VBN
cord-344375-pr6jlc5c	12	20	and	and	CC
cord-344375-pr6jlc5c	12	21	the	the	DT
cord-344375-pr6jlc5c	12	22	presence	presence	NN
cord-344375-pr6jlc5c	12	23	of	of	IN
cord-344375-pr6jlc5c	12	24	VTE	VTE	NNP
cord-344375-pr6jlc5c	12	25	has	have	VBZ
cord-344375-pr6jlc5c	12	26	been	be	VBN
cord-344375-pr6jlc5c	12	27	shown	show	VBN
cord-344375-pr6jlc5c	12	28	to	to	TO
cord-344375-pr6jlc5c	12	29	be	be	VB
cord-344375-pr6jlc5c	12	30	a	a	DT
cord-344375-pr6jlc5c	12	31	poor	poor	JJ
cord-344375-pr6jlc5c	12	32	prognostic	prognostic	JJ
cord-344375-pr6jlc5c	12	33	indicator	indicator	NN
cord-344375-pr6jlc5c	12	34	in	in	IN
cord-344375-pr6jlc5c	12	35	severe	severe	JJ
cord-344375-pr6jlc5c	12	36	COVID-19	covid-19	JJ
cord-344375-pr6jlc5c	12	37	patients	patient	NNS
cord-344375-pr6jlc5c	12	38	[	[	-LRB-
cord-344375-pr6jlc5c	12	39	4	4	CD
cord-344375-pr6jlc5c	12	40	]	]	-RRB-
cord-344375-pr6jlc5c	12	41	.	.	.
cord-344375-pr6jlc5c	13	1	The	the	DT
cord-344375-pr6jlc5c	13	2	extent	extent	NN
cord-344375-pr6jlc5c	13	3	to	to	TO
cord-344375-pr6jlc5c	13	4	which	which	WDT
cord-344375-pr6jlc5c	13	5	the	the	DT
cord-344375-pr6jlc5c	13	6	risk	risk	NN
cord-344375-pr6jlc5c	13	7	of	of	IN
cord-344375-pr6jlc5c	13	8	hypercoagulability	hypercoagulability	NN
cord-344375-pr6jlc5c	13	9	exists	exist	VBZ
cord-344375-pr6jlc5c	13	10	in	in	IN
cord-344375-pr6jlc5c	13	11	the	the	DT
cord-344375-pr6jlc5c	13	12	outpatient	outpatient	NN
cord-344375-pr6jlc5c	13	13	setting	setting	NN
cord-344375-pr6jlc5c	13	14	is	be	VBZ
cord-344375-pr6jlc5c	13	15	unknown	unknown	JJ
cord-344375-pr6jlc5c	13	16	but	but	CC
cord-344375-pr6jlc5c	13	17	has	have	VBZ
cord-344375-pr6jlc5c	13	18	serious	serious	JJ
cord-344375-pr6jlc5c	13	19	implications	implication	NNS
cord-344375-pr6jlc5c	13	20	for	for	IN
cord-344375-pr6jlc5c	13	21	outpatient	outpatient	NN
cord-344375-pr6jlc5c	13	22	and	and	CC
cord-344375-pr6jlc5c	13	23	primary	primary	JJ
cord-344375-pr6jlc5c	13	24	care	care	NN
cord-344375-pr6jlc5c	13	25	providers	provider	NNS
cord-344375-pr6jlc5c	13	26	(	(	-LRB-
cord-344375-pr6jlc5c	13	27	PCP	PCP	NNP
cord-344375-pr6jlc5c	13	28	)	)	-RRB-
cord-344375-pr6jlc5c	13	29	.	.	.
cord-344375-pr6jlc5c	14	1	In	in	IN
cord-344375-pr6jlc5c	14	2	the	the	DT
cord-344375-pr6jlc5c	14	3	inpatient	inpatient	NN
cord-344375-pr6jlc5c	14	4	setting	setting	NN
cord-344375-pr6jlc5c	14	5	,	,	,
cord-344375-pr6jlc5c	14	6	patients	patient	NNS
cord-344375-pr6jlc5c	14	7	with	with	IN
cord-344375-pr6jlc5c	14	8	severe	severe	JJ
cord-344375-pr6jlc5c	14	9	SARS	SARS	NNP
cord-344375-pr6jlc5c	14	10	-	-	HYPH
cord-344375-pr6jlc5c	14	11	CoV-2	CoV-2	NNP
cord-344375-pr6jlc5c	14	12	infections	infection	NNS
cord-344375-pr6jlc5c	14	13	leading	lead	VBG
cord-344375-pr6jlc5c	14	14	to	to	IN
cord-344375-pr6jlc5c	14	15	pneumonia	pneumonia	NN
cord-344375-pr6jlc5c	14	16	and	and	CC
cord-344375-pr6jlc5c	14	17	hypoxic	hypoxic	JJ
cord-344375-pr6jlc5c	14	18	respiratory	respiratory	JJ
cord-344375-pr6jlc5c	14	19	failure	failure	NN
cord-344375-pr6jlc5c	14	20	demonstrate	demonstrate	VBP
cord-344375-pr6jlc5c	14	21	elevated	elevate	VBN
cord-344375-pr6jlc5c	14	22	D	d	NN
cord-344375-pr6jlc5c	14	23	-	-	HYPH
cord-344375-pr6jlc5c	14	24	dimer	dimer	NN
cord-344375-pr6jlc5c	14	25	and	and	CC
cord-344375-pr6jlc5c	14	26	fibrinogen	fibrinogen	NN
cord-344375-pr6jlc5c	14	27	,	,	,
cord-344375-pr6jlc5c	14	28	evidencing	evidence	VBG
cord-344375-pr6jlc5c	14	29	a	a	DT
cord-344375-pr6jlc5c	14	30	hypercoagulable	hypercoagulable	JJ
cord-344375-pr6jlc5c	14	31	state	state	NN
cord-344375-pr6jlc5c	14	32	[	[	-LRB-
cord-344375-pr6jlc5c	14	33	5	5	CD
cord-344375-pr6jlc5c	14	34	]	]	-RRB-
cord-344375-pr6jlc5c	14	35	.	.	.
cord-344375-pr6jlc5c	15	1	The	the	DT
cord-344375-pr6jlc5c	15	2	underlying	underlying	JJ
cord-344375-pr6jlc5c	15	3	pathophysiology	pathophysiology	NN
cord-344375-pr6jlc5c	15	4	contributing	contribute	VBG
cord-344375-pr6jlc5c	15	5	to	to	IN
cord-344375-pr6jlc5c	15	6	the	the	DT
cord-344375-pr6jlc5c	15	7	hypercoagulable	hypercoagulable	JJ
cord-344375-pr6jlc5c	15	8	state	state	NN
cord-344375-pr6jlc5c	15	9	may	may	MD
cord-344375-pr6jlc5c	15	10	be	be	VB
cord-344375-pr6jlc5c	15	11	related	relate	VBN
cord-344375-pr6jlc5c	15	12	to	to	IN
cord-344375-pr6jlc5c	15	13	cytokine	cytokine	JJ
cord-344375-pr6jlc5c	15	14	storm	storm	NN
cord-344375-pr6jlc5c	15	15	inducing	induce	VBG
cord-344375-pr6jlc5c	15	16	endothelial	endothelial	JJ
cord-344375-pr6jlc5c	15	17	damage	damage	NN
cord-344375-pr6jlc5c	15	18	,	,	,
cord-344375-pr6jlc5c	15	19	microvascular	microvascular	JJ
cord-344375-pr6jlc5c	15	20	thrombosis	thrombosis	NN
cord-344375-pr6jlc5c	15	21	,	,	,
cord-344375-pr6jlc5c	15	22	and/or	and/or	CC
cord-344375-pr6jlc5c	15	23	to	to	IN
cord-344375-pr6jlc5c	15	24	the	the	DT
cord-344375-pr6jlc5c	15	25	development	development	NN
cord-344375-pr6jlc5c	15	26	of	of	IN
cord-344375-pr6jlc5c	15	27	prothrombotic	prothrombotic	NNP
cord-344375-pr6jlc5c	15	28	antiphospholipid	antiphospholipid	NNP
cord-344375-pr6jlc5c	15	29	antibodies	antibody	NNS
cord-344375-pr6jlc5c	15	30	.	.	.
cord-344375-pr6jlc5c	16	1	[	[	-LRB-
cord-344375-pr6jlc5c	16	2	6	6	CD
cord-344375-pr6jlc5c	16	3	]	]	-RRB-
cord-344375-pr6jlc5c	17	1	In	in	IN
cord-344375-pr6jlc5c	17	2	patients	patient	NNS
cord-344375-pr6jlc5c	17	3	with	with	IN
cord-344375-pr6jlc5c	17	4	severe	severe	JJ
cord-344375-pr6jlc5c	17	5	COVID	COVID	NNP
cord-344375-pr6jlc5c	17	6	,	,	,
cord-344375-pr6jlc5c	17	7	elevated	elevated	JJ
cord-344375-pr6jlc5c	17	8	D	d	NN
cord-344375-pr6jlc5c	17	9	-	-	HYPH
cord-344375-pr6jlc5c	17	10	dimer	dimer	NN
cord-344375-pr6jlc5c	17	11	correlated	correlate	VBD
cord-344375-pr6jlc5c	17	12	positively	positively	RB
cord-344375-pr6jlc5c	17	13	with	with	IN
cord-344375-pr6jlc5c	17	14	increased	increase	VBN
cord-344375-pr6jlc5c	17	15	28-day	28-day	CD
cord-344375-pr6jlc5c	17	16	mortality	mortality	NN
cord-344375-pr6jlc5c	17	17	[	[	-LRB-
cord-344375-pr6jlc5c	17	18	7	7	CD
cord-344375-pr6jlc5c	17	19	]	]	-RRB-
cord-344375-pr6jlc5c	17	20	and	and	CC
cord-344375-pr6jlc5c	17	21	current	current	JJ
cord-344375-pr6jlc5c	17	22	guidelines	guideline	NNS
cord-344375-pr6jlc5c	17	23	recommend	recommend	VBP
cord-344375-pr6jlc5c	17	24	therapeutic	therapeutic	JJ
cord-344375-pr6jlc5c	17	25	anti	anti	NNP
cord-344375-pr6jlc5c	17	26	-	-	NNP
cord-344375-pr6jlc5c	17	27	Journal	journal	JJ
cord-344375-pr6jlc5c	17	28	Pre	Pre	NNP
cord-344375-pr6jlc5c	17	29	-	-	NN
cord-344375-pr6jlc5c	17	30	proof	proof	JJ
cord-344375-pr6jlc5c	17	31	J	J	NNP
cord-344375-pr6jlc5c	17	32	o	o	NN
cord-344375-pr6jlc5c	17	33	u	u	NN
cord-344375-pr6jlc5c	17	34	r	r	NN
cord-344375-pr6jlc5c	17	35	n	n	NN
cord-344375-pr6jlc5c	17	36	a	a	DT
cord-344375-pr6jlc5c	17	37	l	l	NN
cord-344375-pr6jlc5c	17	38	P	p	NN
cord-344375-pr6jlc5c	17	39	r	r	NN
cord-344375-pr6jlc5c	17	40	e	e	NN
cord-344375-pr6jlc5c	17	41	-p	-p	NN
cord-344375-pr6jlc5c	18	1	r	r	NN
cord-344375-pr6jlc5c	18	2	o	o	NN
cord-344375-pr6jlc5c	18	3	o	o	NN
cord-344375-pr6jlc5c	18	4	f	f	NN
cord-344375-pr6jlc5c	18	5	coagulation	coagulation	NN
cord-344375-pr6jlc5c	18	6	in	in	IN
cord-344375-pr6jlc5c	18	7	the	the	DT
cord-344375-pr6jlc5c	18	8	setting	setting	NN
cord-344375-pr6jlc5c	18	9	of	of	IN
cord-344375-pr6jlc5c	18	10	elevated	elevated	JJ
cord-344375-pr6jlc5c	18	11	D	d	NN
cord-344375-pr6jlc5c	18	12	-	-	HYPH
cord-344375-pr6jlc5c	18	13	dimers	dimer	NNS
cord-344375-pr6jlc5c	18	14	,	,	,
cord-344375-pr6jlc5c	18	15	as	as	IN
cord-344375-pr6jlc5c	18	16	a	a	DT
cord-344375-pr6jlc5c	18	17	high	high	JJ
cord-344375-pr6jlc5c	18	18	incidence	incidence	NN
cord-344375-pr6jlc5c	18	19	of	of	IN
cord-344375-pr6jlc5c	18	20	VTE	VTE	NNP
cord-344375-pr6jlc5c	18	21	has	have	VBZ
cord-344375-pr6jlc5c	18	22	been	be	VBN
cord-344375-pr6jlc5c	18	23	reported	report	VBN
cord-344375-pr6jlc5c	18	24	on	on	IN
cord-344375-pr6jlc5c	18	25	prophylactic	prophylactic	JJ
cord-344375-pr6jlc5c	18	26	dosing	dosing	NN
cord-344375-pr6jlc5c	18	27	[	[	-LRB-
cord-344375-pr6jlc5c	18	28	8	8	CD
cord-344375-pr6jlc5c	18	29	]	]	-RRB-
cord-344375-pr6jlc5c	18	30	.	.	.
cord-344375-pr6jlc5c	19	1	The	the	DT
cord-344375-pr6jlc5c	19	2	prognostic	prognostic	JJ
cord-344375-pr6jlc5c	19	3	value	value	NN
cord-344375-pr6jlc5c	19	4	of	of	IN
cord-344375-pr6jlc5c	19	5	D	d	NN
cord-344375-pr6jlc5c	19	6	-	-	HYPH
cord-344375-pr6jlc5c	19	7	dimers	dimer	NNS
cord-344375-pr6jlc5c	19	8	and	and	CC
cord-344375-pr6jlc5c	19	9	anti	anti	JJ
cord-344375-pr6jlc5c	19	10	-	-	JJ
cord-344375-pr6jlc5c	19	11	coagulation	coagulation	JJ
cord-344375-pr6jlc5c	19	12	benefit	benefit	NN
cord-344375-pr6jlc5c	19	13	in	in	IN
cord-344375-pr6jlc5c	19	14	mild	mild	JJ
cord-344375-pr6jlc5c	19	15	disease	disease	NN
cord-344375-pr6jlc5c	19	16	remains	remain	VBZ
cord-344375-pr6jlc5c	19	17	unknown	unknown	JJ
cord-344375-pr6jlc5c	19	18	.	.	.
cord-344375-pr6jlc5c	20	1	The	the	DT
cord-344375-pr6jlc5c	20	2	pathophysiologic	pathophysiologic	JJ
cord-344375-pr6jlc5c	20	3	differences	difference	NNS
cord-344375-pr6jlc5c	20	4	between	between	IN
cord-344375-pr6jlc5c	20	5	patients	patient	NNS
cord-344375-pr6jlc5c	20	6	with	with	IN
cord-344375-pr6jlc5c	20	7	severe	severe	JJ
cord-344375-pr6jlc5c	20	8	and	and	CC
cord-344375-pr6jlc5c	20	9	mild	mild	JJ
cord-344375-pr6jlc5c	20	10	disease	disease	NN
cord-344375-pr6jlc5c	20	11	is	be	VBZ
cord-344375-pr6jlc5c	20	12	currently	currently	RB
cord-344375-pr6jlc5c	20	13	being	be	VBG
cord-344375-pr6jlc5c	20	14	worked	work	VBN
cord-344375-pr6jlc5c	20	15	out	out	RP
cord-344375-pr6jlc5c	20	16	,	,	,
cord-344375-pr6jlc5c	20	17	however	however	RB
cord-344375-pr6jlc5c	20	18	patients	patient	NNS
cord-344375-pr6jlc5c	20	19	with	with	IN
cord-344375-pr6jlc5c	20	20	mild	mild	JJ
cord-344375-pr6jlc5c	20	21	disease	disease	NN
cord-344375-pr6jlc5c	20	22	demonstrate	demonstrate	VBP
cord-344375-pr6jlc5c	20	23	decreased	decrease	VBN
cord-344375-pr6jlc5c	20	24	lymphocyte	lymphocyte	NN
cord-344375-pr6jlc5c	20	25	count	count	NN
cord-344375-pr6jlc5c	20	26	with	with	IN
cord-344375-pr6jlc5c	20	27	increases	increase	NNS
cord-344375-pr6jlc5c	20	28	in	in	IN
cord-344375-pr6jlc5c	20	29	plasma	plasma	NN
cord-344375-pr6jlc5c	20	30	IL-6	IL-6	NNP
cord-344375-pr6jlc5c	20	31	concentrations	concentration	NNS
cord-344375-pr6jlc5c	20	32	,	,	,
cord-344375-pr6jlc5c	20	33	suggesting	suggest	VBG
cord-344375-pr6jlc5c	20	34	the	the	DT
cord-344375-pr6jlc5c	20	35	presence	presence	NN
cord-344375-pr6jlc5c	20	36	of	of	IN
cord-344375-pr6jlc5c	20	37	an	an	DT
cord-344375-pr6jlc5c	20	38	activated	activate	VBN
cord-344375-pr6jlc5c	20	39	underlying	underlie	VBG
cord-344375-pr6jlc5c	20	40	inflammatory	inflammatory	JJ
cord-344375-pr6jlc5c	20	41	cascade	cascade	NN
cord-344375-pr6jlc5c	20	42	[	[	-LRB-
cord-344375-pr6jlc5c	20	43	9	9	CD
cord-344375-pr6jlc5c	20	44	]	]	-RRB-
cord-344375-pr6jlc5c	20	45	.	.	.
cord-344375-pr6jlc5c	21	1	Comparable	comparable	JJ
cord-344375-pr6jlc5c	21	2	to	to	IN
cord-344375-pr6jlc5c	21	3	hospitalized	hospitalize	VBN
cord-344375-pr6jlc5c	21	4	patients	patient	NNS
cord-344375-pr6jlc5c	21	5	,	,	,
cord-344375-pr6jlc5c	21	6	this	this	DT
cord-344375-pr6jlc5c	21	7	proinflammatory	proinflammatory	JJ
cord-344375-pr6jlc5c	21	8	state	state	NN
cord-344375-pr6jlc5c	21	9	may	may	MD
cord-344375-pr6jlc5c	21	10	predispose	predispose	VB
cord-344375-pr6jlc5c	21	11	outpatients	outpatient	NNS
cord-344375-pr6jlc5c	21	12	to	to	IN
cord-344375-pr6jlc5c	21	13	the	the	DT
cord-344375-pr6jlc5c	21	14	development	development	NN
cord-344375-pr6jlc5c	21	15	of	of	IN
cord-344375-pr6jlc5c	21	16	VTE	VTE	NNP
cord-344375-pr6jlc5c	21	17	and	and	CC
cord-344375-pr6jlc5c	21	18	portend	portend	VBP
cord-344375-pr6jlc5c	21	19	a	a	DT
cord-344375-pr6jlc5c	21	20	worse	bad	JJR
cord-344375-pr6jlc5c	21	21	outcome	outcome	NN
cord-344375-pr6jlc5c	21	22	.	.	.
cord-344375-pr6jlc5c	22	1	Prior	prior	JJ
cord-344375-pr6jlc5c	22	2	studies	study	NNS
cord-344375-pr6jlc5c	22	3	have	have	VBP
cord-344375-pr6jlc5c	22	4	demonstrated	demonstrate	VBN
cord-344375-pr6jlc5c	22	5	an	an	DT
cord-344375-pr6jlc5c	22	6	association	association	NN
cord-344375-pr6jlc5c	22	7	between	between	IN
cord-344375-pr6jlc5c	22	8	proinflammatory	proinflammatory	JJ
cord-344375-pr6jlc5c	22	9	cytokines	cytokine	NNS
cord-344375-pr6jlc5c	22	10	and	and	CC
cord-344375-pr6jlc5c	22	11	onset	onset	NN
cord-344375-pr6jlc5c	22	12	of	of	IN
cord-344375-pr6jlc5c	22	13	VTE	VTE	NNP
cord-344375-pr6jlc5c	22	14	[	[	-LRB-
cord-344375-pr6jlc5c	22	15	10	10	CD
cord-344375-pr6jlc5c	22	16	,	,	,
cord-344375-pr6jlc5c	22	17	11	11	CD
cord-344375-pr6jlc5c	22	18	]	]	-RRB-
cord-344375-pr6jlc5c	22	19	.	.	.
cord-344375-pr6jlc5c	23	1	Moreover	moreover	RB
cord-344375-pr6jlc5c	23	2	,	,	,
cord-344375-pr6jlc5c	23	3	studies	study	NNS
cord-344375-pr6jlc5c	23	4	of	of	IN
cord-344375-pr6jlc5c	23	5	outpatients	outpatient	NNS
cord-344375-pr6jlc5c	23	6	with	with	IN
cord-344375-pr6jlc5c	23	7	VTE	VTE	NNP
cord-344375-pr6jlc5c	23	8	demonstrated	demonstrate	VBD
cord-344375-pr6jlc5c	23	9	that	that	IN
cord-344375-pr6jlc5c	23	10	about	about	IN
cord-344375-pr6jlc5c	23	11	1/5	1/5	CD
cord-344375-pr6jlc5c	23	12	of	of	IN
cord-344375-pr6jlc5c	23	13	patients	patient	NNS
cord-344375-pr6jlc5c	23	14	had	have	VBD
cord-344375-pr6jlc5c	23	15	a	a	DT
cord-344375-pr6jlc5c	23	16	recent	recent	JJ
cord-344375-pr6jlc5c	23	17	infection	infection	NN
cord-344375-pr6jlc5c	23	18	,	,	,
cord-344375-pr6jlc5c	23	19	suggesting	suggest	VBG
cord-344375-pr6jlc5c	23	20	the	the	DT
cord-344375-pr6jlc5c	23	21	recent	recent	JJ
cord-344375-pr6jlc5c	23	22	setting	setting	NN
cord-344375-pr6jlc5c	23	23	of	of	IN
cord-344375-pr6jlc5c	23	24	inflammation	inflammation	NN
cord-344375-pr6jlc5c	23	25	from	from	IN
cord-344375-pr6jlc5c	23	26	infection	infection	NN
cord-344375-pr6jlc5c	23	27	may	may	MD
cord-344375-pr6jlc5c	23	28	contribute	contribute	VB
cord-344375-pr6jlc5c	23	29	to	to	IN
cord-344375-pr6jlc5c	23	30	VTE	VTE	NNP
cord-344375-pr6jlc5c	23	31	risk	risk	NN
cord-344375-pr6jlc5c	23	32	.	.	.
cord-344375-pr6jlc5c	24	1	It	-PRON-	PRP
cord-344375-pr6jlc5c	24	2	stands	stand	VBZ
cord-344375-pr6jlc5c	24	3	to	to	TO
cord-344375-pr6jlc5c	24	4	reason	reason	VB
cord-344375-pr6jlc5c	24	5	that	that	DT
cord-344375-pr6jlc5c	24	6	viral	viral	JJ
cord-344375-pr6jlc5c	24	7	infection	infection	NN
cord-344375-pr6jlc5c	24	8	from	from	IN
cord-344375-pr6jlc5c	24	9	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	24	10	,	,	,
cord-344375-pr6jlc5c	24	11	which	which	WDT
cord-344375-pr6jlc5c	24	12	has	have	VBZ
cord-344375-pr6jlc5c	24	13	demonstrated	demonstrate	VBN
cord-344375-pr6jlc5c	24	14	remarkable	remarkable	JJ
cord-344375-pr6jlc5c	24	15	elevations	elevation	NNS
cord-344375-pr6jlc5c	24	16	in	in	IN
cord-344375-pr6jlc5c	24	17	hematological	hematological	JJ
cord-344375-pr6jlc5c	24	18	markers	marker	NNS
cord-344375-pr6jlc5c	24	19	of	of	IN
cord-344375-pr6jlc5c	24	20	coagulation	coagulation	NN
cord-344375-pr6jlc5c	24	21	[	[	-LRB-
cord-344375-pr6jlc5c	24	22	12	12	CD
cord-344375-pr6jlc5c	24	23	]	]	-RRB-
cord-344375-pr6jlc5c	24	24	,	,	,
cord-344375-pr6jlc5c	24	25	would	would	MD
cord-344375-pr6jlc5c	24	26	increase	increase	VB
cord-344375-pr6jlc5c	24	27	this	this	DT
cord-344375-pr6jlc5c	24	28	risk	risk	NN
cord-344375-pr6jlc5c	24	29	further	far	RBR
cord-344375-pr6jlc5c	24	30	,	,	,
cord-344375-pr6jlc5c	24	31	especially	especially	RB
cord-344375-pr6jlc5c	24	32	as	as	IN
cord-344375-pr6jlc5c	24	33	similar	similar	JJ
cord-344375-pr6jlc5c	24	34	findings	finding	NNS
cord-344375-pr6jlc5c	24	35	were	be	VBD
cord-344375-pr6jlc5c	24	36	seen	see	VBN
cord-344375-pr6jlc5c	24	37	in	in	IN
cord-344375-pr6jlc5c	24	38	patients	patient	NNS
cord-344375-pr6jlc5c	24	39	with	with	IN
cord-344375-pr6jlc5c	24	40	severe	severe	JJ
cord-344375-pr6jlc5c	24	41	acute	acute	JJ
cord-344375-pr6jlc5c	24	42	respiratory	respiratory	JJ
cord-344375-pr6jlc5c	24	43	syndrome	syndrome	NN
cord-344375-pr6jlc5c	24	44	(	(	-LRB-
cord-344375-pr6jlc5c	24	45	SARS	SARS	NNP
cord-344375-pr6jlc5c	24	46	)	)	-RRB-
cord-344375-pr6jlc5c	24	47	,	,	,
cord-344375-pr6jlc5c	24	48	a	a	DT
cord-344375-pr6jlc5c	24	49	related	related	JJ
cord-344375-pr6jlc5c	24	50	coronavirus	coronavirus	NN
cord-344375-pr6jlc5c	24	51	[	[	-LRB-
cord-344375-pr6jlc5c	24	52	13	13	CD
cord-344375-pr6jlc5c	24	53	]	]	-RRB-
cord-344375-pr6jlc5c	24	54	.	.	.
cord-344375-pr6jlc5c	25	1	Patients	patient	NNS
cord-344375-pr6jlc5c	25	2	with	with	IN
cord-344375-pr6jlc5c	25	3	acute	acute	JJ
cord-344375-pr6jlc5c	25	4	medical	medical	JJ
cord-344375-pr6jlc5c	25	5	illness	illness	NN
cord-344375-pr6jlc5c	25	6	are	be	VBP
cord-344375-pr6jlc5c	25	7	at	at	IN
cord-344375-pr6jlc5c	25	8	elevated	elevated	JJ
cord-344375-pr6jlc5c	25	9	VTE	VTE	NNP
cord-344375-pr6jlc5c	25	10	risk	risk	NN
cord-344375-pr6jlc5c	25	11	for	for	IN
cord-344375-pr6jlc5c	25	12	up	up	IN
cord-344375-pr6jlc5c	25	13	to	to	TO
cord-344375-pr6jlc5c	25	14	90	90	CD
cord-344375-pr6jlc5c	25	15	days	day	NNS
cord-344375-pr6jlc5c	25	16	postdischarge	postdischarge	NNP
cord-344375-pr6jlc5c	25	17	[	[	-LRB-
cord-344375-pr6jlc5c	25	18	14	14	CD
cord-344375-pr6jlc5c	25	19	]	]	-RRB-
cord-344375-pr6jlc5c	25	20	.	.	.
cord-344375-pr6jlc5c	26	1	Specific	specific	JJ
cord-344375-pr6jlc5c	26	2	regimens	regimen	NNS
cord-344375-pr6jlc5c	26	3	of	of	IN
cord-344375-pr6jlc5c	26	4	extended	extended	JJ
cord-344375-pr6jlc5c	26	5	thromboprophylaxis	thromboprophylaxis	NN
cord-344375-pr6jlc5c	26	6	may	may	MD
cord-344375-pr6jlc5c	26	7	include	include	VB
cord-344375-pr6jlc5c	26	8	betrixaban	betrixaban	NNP
cord-344375-pr6jlc5c	26	9	J	J	NNP
cord-344375-pr6jlc5c	26	10	o	o	NN
cord-344375-pr6jlc5c	26	11	u	u	NN
cord-344375-pr6jlc5c	26	12	r	r	NN
cord-344375-pr6jlc5c	26	13	n	n	NN
cord-344375-pr6jlc5c	26	14	a	a	DT
cord-344375-pr6jlc5c	26	15	l	l	NN
cord-344375-pr6jlc5c	26	16	P	p	NN
cord-344375-pr6jlc5c	26	17	r	r	NN
cord-344375-pr6jlc5c	26	18	e	e	NN
cord-344375-pr6jlc5c	26	19	-p	-p	NN
cord-344375-pr6jlc5c	27	1	r	r	NNP
cord-344375-pr6jlc5c	27	2	o	o	NN
cord-344375-pr6jlc5c	27	3	o	o	NN
cord-344375-pr6jlc5c	27	4	f	f	NN
cord-344375-pr6jlc5c	27	5	patients	patient	NNS
cord-344375-pr6jlc5c	27	6	to	to	TO
cord-344375-pr6jlc5c	27	7	consider	consider	VB
cord-344375-pr6jlc5c	27	8	stopping	stop	VBG
cord-344375-pr6jlc5c	27	9	pro	pro	JJ
cord-344375-pr6jlc5c	27	10	-	-	JJ
cord-344375-pr6jlc5c	27	11	thrombotic	thrombotic	JJ
cord-344375-pr6jlc5c	27	12	medications	medication	NNS
cord-344375-pr6jlc5c	27	13	such	such	JJ
cord-344375-pr6jlc5c	27	14	as	as	IN
cord-344375-pr6jlc5c	27	15	selective	selective	JJ
cord-344375-pr6jlc5c	27	16	cyclooxygenase-2	cyclooxygenase-2	NNP
cord-344375-pr6jlc5c	27	17	(	(	-LRB-
cord-344375-pr6jlc5c	27	18	COX-2	COX-2	NNP
cord-344375-pr6jlc5c	27	19	)	)	-RRB-
cord-344375-pr6jlc5c	27	20	inhibitors	inhibitor	NNS
cord-344375-pr6jlc5c	27	21	or	or	CC
cord-344375-pr6jlc5c	27	22	supplements	supplement	NNS
cord-344375-pr6jlc5c	27	23	such	such	JJ
cord-344375-pr6jlc5c	27	24	as	as	IN
cord-344375-pr6jlc5c	27	25	vitamin	vitamin	NN
cord-344375-pr6jlc5c	27	26	K	k	NN
cord-344375-pr6jlc5c	27	27	or	or	CC
cord-344375-pr6jlc5c	27	28	vitamin	vitamin	NN
cord-344375-pr6jlc5c	27	29	E.	E.	NNP
cord-344375-pr6jlc5c	27	30	Studies	Studies	NNPS
cord-344375-pr6jlc5c	27	31	evaluating	evaluate	VBG
cord-344375-pr6jlc5c	27	32	any	any	DT
cord-344375-pr6jlc5c	27	33	benefit	benefit	NN
cord-344375-pr6jlc5c	27	34	versus	versus	IN
cord-344375-pr6jlc5c	27	35	perceived	perceive	VBN
cord-344375-pr6jlc5c	27	36	harm	harm	NN
cord-344375-pr6jlc5c	27	37	from	from	IN
cord-344375-pr6jlc5c	27	38	standard	standard	JJ
cord-344375-pr6jlc5c	27	39	NSAIDS	NSAIDS	NNP
cord-344375-pr6jlc5c	27	40	are	be	VBP
cord-344375-pr6jlc5c	27	41	ongoing	ongoing	JJ
cord-344375-pr6jlc5c	27	42	.	.	.
cord-344375-pr6jlc5c	28	1	With	with	IN
cord-344375-pr6jlc5c	28	2	the	the	DT
cord-344375-pr6jlc5c	28	3	global	global	JJ
cord-344375-pr6jlc5c	28	4	burden	burden	NN
cord-344375-pr6jlc5c	28	5	of	of	IN
cord-344375-pr6jlc5c	28	6	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	28	7	mortality	mortality	NN
cord-344375-pr6jlc5c	28	8	,	,	,
cord-344375-pr6jlc5c	28	9	reaching	reach	VBG
cord-344375-pr6jlc5c	28	10	over	over	IN
cord-344375-pr6jlc5c	28	11	300,000	300,000	CD
cord-344375-pr6jlc5c	28	12	deaths	death	NNS
cord-344375-pr6jlc5c	28	13	worldwide	worldwide	RB
cord-344375-pr6jlc5c	28	14	,	,	,
cord-344375-pr6jlc5c	28	15	little	little	JJ
cord-344375-pr6jlc5c	28	16	is	be	VBZ
cord-344375-pr6jlc5c	28	17	known	know	VBN
cord-344375-pr6jlc5c	28	18	about	about	IN
cord-344375-pr6jlc5c	28	19	the	the	DT
cord-344375-pr6jlc5c	28	20	specific	specific	JJ
cord-344375-pr6jlc5c	28	21	pathogenic	pathogenic	JJ
cord-344375-pr6jlc5c	28	22	viral	viral	JJ
cord-344375-pr6jlc5c	28	23	features	feature	NNS
cord-344375-pr6jlc5c	28	24	and	and	CC
cord-344375-pr6jlc5c	28	25	poor	poor	JJ
cord-344375-pr6jlc5c	28	26	outcomes	outcome	NNS
cord-344375-pr6jlc5c	28	27	in	in	IN
cord-344375-pr6jlc5c	28	28	these	these	DT
cord-344375-pr6jlc5c	28	29	patients	patient	NNS
cord-344375-pr6jlc5c	28	30	.	.	.
cord-344375-pr6jlc5c	29	1	A	a	DT
cord-344375-pr6jlc5c	29	2	recent	recent	JJ
cord-344375-pr6jlc5c	29	3	prospective	prospective	JJ
cord-344375-pr6jlc5c	29	4	study	study	NN
cord-344375-pr6jlc5c	29	5	of	of	IN
cord-344375-pr6jlc5c	29	6	autopsy	autopsy	JJ
cord-344375-pr6jlc5c	29	7	findings	finding	NNS
cord-344375-pr6jlc5c	29	8	from	from	IN
cord-344375-pr6jlc5c	29	9	consecutive	consecutive	JJ
cord-344375-pr6jlc5c	29	10	deaths	death	NNS
cord-344375-pr6jlc5c	29	11	from	from	IN
cord-344375-pr6jlc5c	29	12	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	29	13	found	find	VBD
cord-344375-pr6jlc5c	29	14	thromboembolic	thromboembolic	JJ
cord-344375-pr6jlc5c	29	15	events	event	NNS
cord-344375-pr6jlc5c	29	16	to	to	IN
cord-344375-pr6jlc5c	29	17	an	an	DT
cord-344375-pr6jlc5c	29	18	important	important	JJ
cord-344375-pr6jlc5c	29	19	feature	feature	NN
cord-344375-pr6jlc5c	29	20	of	of	IN
cord-344375-pr6jlc5c	29	21	mortality	mortality	NN
cord-344375-pr6jlc5c	29	22	,	,	,
cord-344375-pr6jlc5c	29	23	with	with	IN
cord-344375-pr6jlc5c	29	24	only	only	RB
cord-344375-pr6jlc5c	29	25	a	a	DT
cord-344375-pr6jlc5c	29	26	small	small	JJ
cord-344375-pr6jlc5c	29	27	proportion	proportion	NN
cord-344375-pr6jlc5c	29	28	of	of	IN
cord-344375-pr6jlc5c	29	29	patients	patient	NNS
cord-344375-pr6jlc5c	29	30	characterized	characterize	VBN
cord-344375-pr6jlc5c	29	31	from	from	IN
cord-344375-pr6jlc5c	29	32	the	the	DT
cord-344375-pr6jlc5c	29	33	outpatient	outpatient	NN
cord-344375-pr6jlc5c	29	34	setting	set	VBG
cord-344375-pr6jlc5c	29	35	[	[	-LRB-
cord-344375-pr6jlc5c	29	36	18	18	CD
cord-344375-pr6jlc5c	29	37	]	]	-RRB-
cord-344375-pr6jlc5c	29	38	.	.	.
cord-344375-pr6jlc5c	30	1	In	in	IN
cord-344375-pr6jlc5c	30	2	the	the	DT
cord-344375-pr6jlc5c	30	3	case	case	NN
cord-344375-pr6jlc5c	30	4	of	of	IN
cord-344375-pr6jlc5c	30	5	patients	patient	NNS
cord-344375-pr6jlc5c	30	6	with	with	IN
cord-344375-pr6jlc5c	30	7	mild	mild	JJ
cord-344375-pr6jlc5c	30	8	symptoms	symptom	NNS
cord-344375-pr6jlc5c	30	9	from	from	IN
cord-344375-pr6jlc5c	30	10	coronavirus	coronavirus	NN
cord-344375-pr6jlc5c	30	11	,	,	,
cord-344375-pr6jlc5c	30	12	risk	risk	NN
cord-344375-pr6jlc5c	30	13	factors	factor	NNS
cord-344375-pr6jlc5c	30	14	should	should	MD
cord-344375-pr6jlc5c	30	15	be	be	VB
cord-344375-pr6jlc5c	30	16	integrated	integrate	VBN
cord-344375-pr6jlc5c	30	17	with	with	IN
cord-344375-pr6jlc5c	30	18	laboratory	laboratory	NN
cord-344375-pr6jlc5c	30	19	data	datum	NNS
cord-344375-pr6jlc5c	30	20	and	and	CC
cord-344375-pr6jlc5c	30	21	emerging	emerge	VBG
cord-344375-pr6jlc5c	30	22	guidelines	guideline	NNS
cord-344375-pr6jlc5c	30	23	to	to	TO
cord-344375-pr6jlc5c	30	24	mitigate	mitigate	VB
cord-344375-pr6jlc5c	30	25	the	the	DT
cord-344375-pr6jlc5c	30	26	risks	risk	NNS
cord-344375-pr6jlc5c	30	27	of	of	IN
cord-344375-pr6jlc5c	30	28	thromboembolism	thromboembolism	NN
cord-344375-pr6jlc5c	30	29	.	.	.
cord-344375-pr6jlc5c	31	1	Further	further	JJ
cord-344375-pr6jlc5c	31	2	investigations	investigation	NNS
cord-344375-pr6jlc5c	31	3	from	from	IN
cord-344375-pr6jlc5c	31	4	the	the	DT
cord-344375-pr6jlc5c	31	5	outpatient	outpatient	NN
cord-344375-pr6jlc5c	31	6	setting	setting	NN
cord-344375-pr6jlc5c	31	7	of	of	IN
cord-344375-pr6jlc5c	31	8	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	31	9	are	be	VBP
cord-344375-pr6jlc5c	31	10	warranted	warrant	VBN
cord-344375-pr6jlc5c	31	11	with	with	IN
cord-344375-pr6jlc5c	31	12	high	high	JJ
cord-344375-pr6jlc5c	31	13	priority	priority	NN
cord-344375-pr6jlc5c	31	14	,	,	,
cord-344375-pr6jlc5c	31	15	as	as	IN
cord-344375-pr6jlc5c	31	16	the	the	DT
cord-344375-pr6jlc5c	31	17	global	global	JJ
cord-344375-pr6jlc5c	31	18	impact	impact	NN
cord-344375-pr6jlc5c	31	19	of	of	IN
cord-344375-pr6jlc5c	31	20	optimizing	optimize	VBG
cord-344375-pr6jlc5c	31	21	risk	risk	NN
cord-344375-pr6jlc5c	31	22	-	-	HYPH
cord-344375-pr6jlc5c	31	23	management	management	NN
cord-344375-pr6jlc5c	31	24	in	in	IN
cord-344375-pr6jlc5c	31	25	these	these	DT
cord-344375-pr6jlc5c	31	26	patients	patient	NNS
cord-344375-pr6jlc5c	31	27	extends	extend	VBZ
cord-344375-pr6jlc5c	31	28	far	far	RB
cord-344375-pr6jlc5c	31	29	beyond	beyond	IN
cord-344375-pr6jlc5c	31	30	VTE	VTE	NNP
cord-344375-pr6jlc5c	31	31	prevention	prevention	NN
cord-344375-pr6jlc5c	31	32	alone	alone	RB
cord-344375-pr6jlc5c	31	33	.	.	.
cord-344375-pr6jlc5c	32	1	The	the	DT
cord-344375-pr6jlc5c	32	2	epidemiology	epidemiology	NN
cord-344375-pr6jlc5c	32	3	and	and	CC
cord-344375-pr6jlc5c	32	4	pathogenesis	pathogenesis	NN
cord-344375-pr6jlc5c	32	5	of	of	IN
cord-344375-pr6jlc5c	32	6	coronavirus	coronavirus	NN
cord-344375-pr6jlc5c	32	7	disease	disease	NN
cord-344375-pr6jlc5c	32	8	(	(	-LRB-
cord-344375-pr6jlc5c	32	9	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	32	10	)	)	-RRB-
cord-344375-pr6jlc5c	32	11	outbreak	outbreak	NN
cord-344375-pr6jlc5c	33	1	Mild	mild	JJ
cord-344375-pr6jlc5c	33	2	or	or	CC
cord-344375-pr6jlc5c	33	3	Moderate	moderate	JJ
cord-344375-pr6jlc5c	33	4	Covid-19	covid-19	JJ
cord-344375-pr6jlc5c	33	5	Pulmonary	pulmonary	JJ
cord-344375-pr6jlc5c	33	6	embolism	embolism	NN
cord-344375-pr6jlc5c	33	7	in	in	IN
cord-344375-pr6jlc5c	33	8	patients	patient	NNS
cord-344375-pr6jlc5c	33	9	with	with	IN
cord-344375-pr6jlc5c	33	10	Covid-19	covid-19	JJ
cord-344375-pr6jlc5c	33	11	pneumonia	pneumonia	NN
cord-344375-pr6jlc5c	33	12	Prevalence	prevalence	NN
cord-344375-pr6jlc5c	33	13	of	of	IN
cord-344375-pr6jlc5c	33	14	venous	venous	JJ
cord-344375-pr6jlc5c	33	15	thromboembolism	thromboembolism	NN
cord-344375-pr6jlc5c	33	16	in	in	IN
cord-344375-pr6jlc5c	33	17	patients	patient	NNS
cord-344375-pr6jlc5c	33	18	with	with	IN
cord-344375-pr6jlc5c	33	19	severe	severe	JJ
cord-344375-pr6jlc5c	33	20	novel	novel	JJ
cord-344375-pr6jlc5c	33	21	coronavirus	coronavirus	NN
cord-344375-pr6jlc5c	33	22	pneumonia	pneumonia	NN
cord-344375-pr6jlc5c	33	23	Hypercoagulability	Hypercoagulability	NNP
cord-344375-pr6jlc5c	33	24	of	of	IN
cord-344375-pr6jlc5c	33	25	COVID-19	covid-19	JJ
cord-344375-pr6jlc5c	33	26	patients	patient	NNS
cord-344375-pr6jlc5c	33	27	in	in	IN
cord-344375-pr6jlc5c	33	28	Intensive	Intensive	NNP
cord-344375-pr6jlc5c	33	29	Care	Care	NNP
cord-344375-pr6jlc5c	33	30	Unit	Unit	NNP
cord-344375-pr6jlc5c	33	31	.	.	.
cord-344375-pr6jlc5c	34	1	A	a	DT
cord-344375-pr6jlc5c	34	2	Report	Report	NNP
cord-344375-pr6jlc5c	34	3	of	of	IN
cord-344375-pr6jlc5c	34	4	Thromboelastography	Thromboelastography	NNP
cord-344375-pr6jlc5c	34	5	Findings	Findings	NNPS
cord-344375-pr6jlc5c	34	6	and	and	CC
cord-344375-pr6jlc5c	34	7	other	other	JJ
cord-344375-pr6jlc5c	34	8	Parameters	parameter	NNS
cord-344375-pr6jlc5c	34	9	of	of	IN
cord-344375-pr6jlc5c	34	10	Hemostasis	Hemostasis	NNP
cord-344375-pr6jlc5c	34	11	Coagulopathy	Coagulopathy	NNP
cord-344375-pr6jlc5c	34	12	and	and	CC
cord-344375-pr6jlc5c	34	13	Antiphospholipid	Antiphospholipid	NNP
cord-344375-pr6jlc5c	34	14	Antibodies	Antibodies	NNPS
cord-344375-pr6jlc5c	34	15	in	in	IN
cord-344375-pr6jlc5c	34	16	Patients	patient	NNS
cord-344375-pr6jlc5c	34	17	with	with	IN
cord-344375-pr6jlc5c	34	18	Covid-19	covid-19	JJ
cord-344375-pr6jlc5c	34	19	Abnormal	abnormal	JJ
cord-344375-pr6jlc5c	34	20	coagulation	coagulation	NN
cord-344375-pr6jlc5c	34	21	parameters	parameter	NNS
cord-344375-pr6jlc5c	34	22	are	be	VBP
cord-344375-pr6jlc5c	34	23	associated	associate	VBN
cord-344375-pr6jlc5c	34	24	with	with	IN
cord-344375-pr6jlc5c	34	25	poor	poor	JJ
cord-344375-pr6jlc5c	34	26	prognosis	prognosis	NN
cord-344375-pr6jlc5c	34	27	in	in	IN
cord-344375-pr6jlc5c	34	28	patients	patient	NNS
cord-344375-pr6jlc5c	34	29	with	with	IN
cord-344375-pr6jlc5c	34	30	novel	novel	JJ
cord-344375-pr6jlc5c	34	31	coronavirus	coronavirus	NN
cord-344375-pr6jlc5c	34	32	pneumonia	pneumonia	NN
cord-344375-pr6jlc5c	34	33	Venous	venous	JJ
cord-344375-pr6jlc5c	34	34	and	and	CC
cord-344375-pr6jlc5c	34	35	arterial	arterial	JJ
cord-344375-pr6jlc5c	34	36	thromboembolic	thromboembolic	JJ
cord-344375-pr6jlc5c	34	37	complications	complication	NNS
cord-344375-pr6jlc5c	34	38	in	in	IN
cord-344375-pr6jlc5c	34	39	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	34	40	patients	patient	NNS
cord-344375-pr6jlc5c	34	41	admitted	admit	VBD
cord-344375-pr6jlc5c	34	42	to	to	IN
cord-344375-pr6jlc5c	34	43	an	an	DT
cord-344375-pr6jlc5c	34	44	academic	academic	JJ
cord-344375-pr6jlc5c	34	45	hospital	hospital	NN
cord-344375-pr6jlc5c	34	46	in	in	IN
cord-344375-pr6jlc5c	34	47	Characteristics	characteristic	NNS
cord-344375-pr6jlc5c	34	48	of	of	IN
cord-344375-pr6jlc5c	34	49	Peripheral	Peripheral	NNP
cord-344375-pr6jlc5c	34	50	Lymphocyte	Lymphocyte	NNP
cord-344375-pr6jlc5c	34	51	Subset	Subset	NNP
cord-344375-pr6jlc5c	34	52	Alteration	Alteration	NNP
cord-344375-pr6jlc5c	34	53	in	in	IN
cord-344375-pr6jlc5c	34	54	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	34	55	Pneumonia	Pneumonia	NNP
cord-344375-pr6jlc5c	35	1	The	the	DT
cord-344375-pr6jlc5c	35	2	role	role	NN
cord-344375-pr6jlc5c	35	3	of	of	IN
cord-344375-pr6jlc5c	35	4	IL-6	IL-6	NNP
cord-344375-pr6jlc5c	35	5	,	,	,
cord-344375-pr6jlc5c	35	6	IL-8	IL-8	NNP
cord-344375-pr6jlc5c	35	7	and	and	CC
cord-344375-pr6jlc5c	35	8	MCP-1	MCP-1	NNP
cord-344375-pr6jlc5c	35	9	and	and	CC
cord-344375-pr6jlc5c	35	10	their	-PRON-	PRP$
cord-344375-pr6jlc5c	35	11	promoter	promoter	NN
cord-344375-pr6jlc5c	35	12	polymorphisms	polymorphism	NNS
cord-344375-pr6jlc5c	35	13	IL-6	IL-6	NNP
cord-344375-pr6jlc5c	35	14	-174GC	-174gc	XX
cord-344375-pr6jlc5c	35	15	,	,	,
cord-344375-pr6jlc5c	35	16	IL-8	IL-8	NNP
cord-344375-pr6jlc5c	35	17	-251AT	-251AT	.
cord-344375-pr6jlc5c	36	1	and	and	CC
cord-344375-pr6jlc5c	36	2	MCP-1	MCP-1	NNP
cord-344375-pr6jlc5c	37	1	-2518AG	-2518ag	CD
cord-344375-pr6jlc5c	38	1	in	in	IN
cord-344375-pr6jlc5c	38	2	the	the	DT
cord-344375-pr6jlc5c	38	3	risk	risk	NN
cord-344375-pr6jlc5c	38	4	of	of	IN
cord-344375-pr6jlc5c	38	5	venous	venous	JJ
cord-344375-pr6jlc5c	38	6	thromboembolism	thromboembolism	NN
cord-344375-pr6jlc5c	38	7	:	:	:
cord-344375-pr6jlc5c	38	8	A	a	DT
cord-344375-pr6jlc5c	38	9	case	case	NN
cord-344375-pr6jlc5c	38	10	-	-	HYPH
cord-344375-pr6jlc5c	38	11	control	control	NN
cord-344375-pr6jlc5c	38	12	study	study	NN
cord-344375-pr6jlc5c	38	13	Venous	venous	JJ
cord-344375-pr6jlc5c	38	14	thromboembolism	thromboembolism	NN
cord-344375-pr6jlc5c	38	15	in	in	IN
cord-344375-pr6jlc5c	38	16	the	the	DT
cord-344375-pr6jlc5c	38	17	outpatient	outpatient	NN
cord-344375-pr6jlc5c	38	18	setting	set	VBG
cord-344375-pr6jlc5c	38	19	Thromboinflammation	Thromboinflammation	NNP
cord-344375-pr6jlc5c	38	20	and	and	CC
cord-344375-pr6jlc5c	38	21	the	the	DT
cord-344375-pr6jlc5c	38	22	hypercoagulability	hypercoagulability	NN
cord-344375-pr6jlc5c	38	23	of	of	IN
cord-344375-pr6jlc5c	38	24	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	38	25	Haematological	Haematological	NNP
cord-344375-pr6jlc5c	38	26	manifestations	manifestation	NNS
cord-344375-pr6jlc5c	38	27	in	in	IN
cord-344375-pr6jlc5c	38	28	patients	patient	NNS
cord-344375-pr6jlc5c	38	29	with	with	IN
cord-344375-pr6jlc5c	38	30	severe	severe	JJ
cord-344375-pr6jlc5c	38	31	acute	acute	JJ
cord-344375-pr6jlc5c	38	32	respiratory	respiratory	JJ
cord-344375-pr6jlc5c	38	33	syndrome	syndrome	NN
cord-344375-pr6jlc5c	38	34	:	:	:
cord-344375-pr6jlc5c	39	1	Retrospective	retrospective	JJ
cord-344375-pr6jlc5c	39	2	analysis	analysis	NN
cord-344375-pr6jlc5c	39	3	COVID-19	covid-19	NN
cord-344375-pr6jlc5c	39	4	and	and	CC
cord-344375-pr6jlc5c	39	5	VTE	VTE	NNP
cord-344375-pr6jlc5c	39	6	-	-	HYPH
cord-344375-pr6jlc5c	39	7	Anticoagulation	Anticoagulation	NNP
cord-344375-pr6jlc5c	39	8	-Hematology.org	-Hematology.org	HYPH
cord-344375-pr6jlc5c	39	9	Hematological	Hematological	NNP
cord-344375-pr6jlc5c	39	10	findings	finding	NNS
cord-344375-pr6jlc5c	39	11	and	and	CC
cord-344375-pr6jlc5c	39	12	complications	complication	NNS
cord-344375-pr6jlc5c	39	13	of	of	IN
cord-344375-pr6jlc5c	39	14	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	39	15	COVID-19	COVID-19	NNP
cord-344375-pr6jlc5c	39	16	and	and	CC
cord-344375-pr6jlc5c	39	17	Thrombotic	Thrombotic	NNP
cord-344375-pr6jlc5c	39	18	or	or	CC
cord-344375-pr6jlc5c	39	19	Thromboembolic	Thromboembolic	NNP
cord-344375-pr6jlc5c	39	20	Disease	Disease	NNP
cord-344375-pr6jlc5c	39	21	:	:	:
cord-344375-pr6jlc5c	39	22	Implications	implication	NNS
cord-344375-pr6jlc5c	39	23	for	for	IN
cord-344375-pr6jlc5c	39	24	Prevention	Prevention	NNP
cord-344375-pr6jlc5c	39	25	,	,	,
cord-344375-pr6jlc5c	39	26	Antithrombotic	Antithrombotic	NNP
cord-344375-pr6jlc5c	39	27	Therapy	Therapy	NNP
cord-344375-pr6jlc5c	39	28	,	,	,
cord-344375-pr6jlc5c	39	29	and	and	CC
cord-344375-pr6jlc5c	39	30	Follow	follow	NN
cord-344375-pr6jlc5c	39	31	-	-	HYPH
cord-344375-pr6jlc5c	39	32	up	up	NN
cord-344375-pr6jlc5c	40	1	A	a	DT
cord-344375-pr6jlc5c	40	2	risk	risk	NN
cord-344375-pr6jlc5c	40	3	assessment	assessment	NN
cord-344375-pr6jlc5c	40	4	model	model	NN
cord-344375-pr6jlc5c	40	5	for	for	IN
cord-344375-pr6jlc5c	40	6	the	the	DT
cord-344375-pr6jlc5c	40	7	identification	identification	NN
cord-344375-pr6jlc5c	40	8	of	of	IN
cord-344375-pr6jlc5c	40	9	hospitalized	hospitalize	VBN
cord-344375-pr6jlc5c	40	10	medical	medical	JJ
cord-344375-pr6jlc5c	40	11	patients	patient	NNS
cord-344375-pr6jlc5c	40	12	at	at	IN
cord-344375-pr6jlc5c	40	13	risk	risk	NN
cord-344375-pr6jlc5c	40	14	for	for	IN
cord-344375-pr6jlc5c	40	15	venous	venous	JJ
cord-344375-pr6jlc5c	40	16	thromboembolism	thromboembolism	NN
cord-344375-pr6jlc5c	41	1	:	:	:
cord-344375-pr6jlc5c	41	2	The	the	DT
cord-344375-pr6jlc5c	41	3	Padua	Padua	NNP
cord-344375-pr6jlc5c	41	4	Prediction	Prediction	NNP
cord-344375-pr6jlc5c	41	5	Score	Score	NNP